Artificial intelligence (AI) is pressing the accelerator button to break through the bottleneck of biomedicine research and development, profoundly changing the medical model. This paper provides an overview of the competitive landscape of AI−enabled biomedicine globally. European and American countries are accelerating the application of AI in the biomedicine and have established a significant first−mover advantage. Then, this paper analyzes the current status of AI−enabled biomedicine in China, which is in the early stages of rapid development, while facing severe challenges such as the heavy burden of major diseases and decoupling from international chains. Moreover, the main issues identified include the lack of high−quality biomedicine data, insufficient underlying original innovation in AI, imperfect policy regulation and industrial chain ecosystem construction, and a shortage of composite talents. Finally, we suggest promoting the construction of a national research−oriented biomedicine data platform, increasing the original innovation of AI for biomedicine, promoting the landing and application of AI in the fields of traditional Chinese medicine, biomedicine, and brain computer interfaces, and increasing the cultivation of versatile talents.
| 科 Family | 属数 Number of genus | 种数 Number of species | 占总种数比例 Percentage of total species (%) | 属 Genus | 种数 Number of species | 占总种数比例 Percentage of total species (%) |
|---|---|---|---|---|---|---|
| 鹅膏菌科Amanitaceae | 2 | 11 | 5.26 | 鹅膏菌属 Amanita | 10 | 4.78 |
| 小菇科 Mycenaceae | 2 | 12 | 5.74 | 丝盖伞属 Inocybe | 5 | 2.39 |
| 多孔菌科 Polyporaceae | 8 | 14 | 6.70 | 蜡蘑属 Laccaria | 5 | 2.39 |
| 红菇科 Russulaceae | 3 | 23 | 11.00 | 小皮伞属 Marasmius | 6 | 2.87 |
| 小菇属 Mycena | 11 | 5.26 | ||||
| 光柄菇属 Pluteus | 5 | 2.39 | ||||
| 红菇属 Russula | 17 | 8.13 | ||||
| 栓菌属 Trametes | 5 | 2.39 |